AT
Accretion Therapeutics, Inc.
SEC filingPharmaceuticals · Lincolnshire, IL
Amount raised$750Ksold at filing
Total offering$1M$250K still open
Investors in the raise1count reported to the SEC
FiledFeb 17, 2026first sale Feb 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David HolecekExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.